BioLife Solutions, Inc. (BLFS) vs LeMaitre Vascular, Inc. (LMAT)
BioLife Solutions, Inc. and LeMaitre Vascular, Inc. are both Medical Instruments & Supplies companies. BioLife Solutions, Inc. and LeMaitre Vascular, Inc. are of similar size ($1.9B and $1.9B). LeMaitre Vascular, Inc. trades at the lower P/E: 28.1× against 32.6×. BioLife Solutions, Inc. grew revenue faster over the last twelve months: 30.1% against 11.9%. BioLife Solutions, Inc. has the higher net margin (54.4% vs 25.0%) and the lower return on invested capital (0.32% vs 22.7%). Across the 22 metrics below, LeMaitre Vascular, Inc. leads on 16 and BioLife Solutions, Inc. on 6.
Valuation
Profitability
| Metric | BLFS | LMAT | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 63.61% | 72.90% | 54.62% |
| Operating margin | 1.64% | 29.46% | 1.64% |
| Net margin | 54.35% | 25.02% | 0.00% |
| Free cash flow margin | 7.60% | 28.13% | 1.61% |
| Return on equity | 15.12% | 16.77% | 0.00% |
| Return on assets | 13.89% | 10.78% | 0.00% |
| Return on invested capital | 0.32% | 22.67% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack